• Trending
  • Latest
    Sign in Sign up
    • Log In
    • Register
    • Home
    • Discover
    • Experts
    • Home
    • Discover
    • Experts
    • Learning Lab
    • Home
    • Discover
    • Experts
    • Learning Lab
    • Mashup Score: 22
      IASLC Names New Chief Science Officer - ILCN.org (ILCN/WCLC) - 1 year(s) ago

      Dr. Jennifer King brings expertise in molecular targets for cancer therapeutics as well as executive-level experience implementing strategic initiatives to the scientific affairs team.

      Source: www.ilcn.org
      Categories: General Medicine News, Hem/Oncs
      Tweet Tweets with this article
      • Profile photo of 	StephenVLiu
        StephenVLiu

        Meet the new @IASLC Chief Science Officer, Dr. Jennifer King @JenniferCKing in the #ILCN! https://t.co/t2VYCuyUl3

    • Mashup Score: 22
      IASLC Names New Chief Science Officer - ILCN.org (ILCN/WCLC) - 1 year(s) ago

      Dr. Jennifer King brings expertise in molecular targets for cancer therapeutics as well as executive-level experience implementing strategic initiatives to the scientific affairs team.

      Source: www.ilcn.org
      Categories: General Medicine News, Hem/Oncs
      Tweet Tweets with this article
      • Profile photo of 	StephenVLiu
        StephenVLiu

        Meet the new @IASLC Chief Science Officer, Dr. Jennifer King @JenniferCKing in the #ILCN! https://t.co/t2VYCuyUl3

    • Mashup Score: 0
      IASLC’s New 5-Year Strategic Plan Unveiled at Business Meeting - ILCN.org (ILCN/WCLC) - 2 year(s) ago

      IASLC leaders also shared highlights from the association’s membership growth and financial report and officially welcomed President Dr. Paul Van Schil.

      Source: www.ilcn.org
      Categories: Hem/Onc News and Journals, Latest Headlines
      Tweet Tweets with this article
      • Profile photo of 	IASLC
        IASLC

        @IASLC unveiled its new 5-Year Strategic Plan at #WCLC23. The association also officially welcomed new President Dr. Paul Van Schil. Learn more in #ILCN. https://t.co/ikqnAK82za #LCSM

    • Mashup Score: 0
      Study Shows Exhaled Breath May Track Treatment Response in Mesothelioma - ILCN.org (ILCN/WCLC) - 2 year(s) ago

      During WCLC 2023, researcher Dr. Kevin Lamote shared data that demonstrated VOCs in exhaled breath could be a useful biomarker.

      Source: www.ilcn.org
      Categories: Hem/Onc News and Journals, Latest Headlines
      Tweet Tweets with this article
      • Profile photo of 	IASLC
        IASLC

        #BreathResearch scientist Dr. Kevin Lamote presented data at #WCLC23 that demonstrated VOCs in exhaled breath may be a useful biomarker in tracking treatment response in #mesothelioma. Learn more in #ILCN. https://t.co/l7Sti5ESLo #LCSM

    • Mashup Score: 0
      First-line Nivolumab + Ipilimumab Superior to Chemotherapy in Metastatic NSCLC at 6 Years - ILCN.org (ILCN/WCLC) - 2 year(s) ago

      Dr. Solange Peters presented new follow-up data from CheckMate 227 that show positive results regardless of PD-L1 expression.

      Source: www.ilcn.org
      Categories: Hem/Onc News and Journals, Latest Headlines
      Tweet Tweets with this article
      • Profile photo of 	IASLC
        IASLC

        During #WCLC23, @peters_solange presented new follow-up data from CheckMate 227 that show positive results regardless of PD-L1 expression. Learn more in #ILCN. https://t.co/MCioXfHQ4O #LCSM

    • Mashup Score: 0
      KRYSTAL-1 Data Demonstrates Durable Adagrasib Response Against Mutated NSCLC - ILCN.org (ILCN/WCLC) - 2 year(s) ago

      After more than 2 years, the median duration of response was 12.4 months and no new safety signals were seen, according to Dr. Shirish Gadgeel, who presented the results during WCLC 2023.

      Source: www.ilcn.org
      Categories: Hem/Onc News and Journals, Latest Headlines
      Tweet Tweets with this article
      • Profile photo of 	IASLC
        IASLC

        After more than 2 years of follow-up, KRYSTAL-1 data showed the median duration of response with adagrasib was 12.4 months, according to Dr. Shirish Gadgeel, who presented the results during #WCLC23. Learn more in #ILCN. https://t.co/BmUHBb2j7m #LCSM

    • Mashup Score: 0
      Lectureship Award Winners Discuss Range of Issues in Thoracic Oncology During WCLC Plenary Session - ILCN.org (ILCN/WCLC) - 2 year(s) ago

      Drs. Silvia Novello, Alan Sihoe, and D. Ross Camidge kicked off the session with forward-looking talks on tobacco control and smoking cessation, surgery, and medical oncology.

      Source: www.ilcn.org
      Categories: Hem/Onc News and Journals, Latest Headlines
      Tweet Tweets with this article
      • Profile photo of 	IASLC
        IASLC

        Drs. Silvia Novello, @ASihoe & D. Ross Camidge kicked off the #WCLC23 Lectureship Awards plenary session with forward-looking talks on tobacco control and smoking cessation, surgery, and medical oncology. Learn more in #ILCN. https://t.co/WNjIA7VkRr #LCSM

    • Mashup Score: 3
      Annual Award Recognizes Importance of Multidisciplinary Teams - ILCN.org (ILCN/WCLC) - 2 year(s) ago

      The IASLC Cancer Care Team award highlights the teamwork required to provide the best possible patient care.

      Source: www.ilcn.org
      Categories: Hem/Onc News and Journals, Latest Headlines
      Tweet Tweets with this article
      • Profile photo of 	IASLC
        IASLC

        Cancer care teams from around the world were honored Saturday at #WCLC23 for the exceptional care they provide their patients. Read more in #ILCN: https://t.co/jFbiuOU1sP #LCSM

    • Mashup Score: 1
      Final Poster Networking Reception Tonight - ILCN.org (ILCN/WCLC) - 2 year(s) ago

      Make time to visit the Exhibit Hall this evening to talk with poster presenters about their research.

      Source: www.ilcn.org
      Categories: Hem/Onc News and Journals, Latest Headlines
      Tweet Tweets with this article
      • Profile photo of 	IASLC
        IASLC

        Make time to visit the #WCLC23 Exhibit Hall this evening to talk with poster presenters about their research. Read more in #ILCN: https://t.co/l8efusPDlM #LCSM

    • Mashup Score: 0
      Plenary 4 Offers Early Look at 9th Edition of TNM Staging Classification for Thoracic Cancers - ILCN.org (ILCN/WCLC) - 2 year(s) ago

      IASLC Staging and Prognostic Factors Committee Chair Dr. Hisao Asamura joins Drs. Valerie Rusch and Enrico Ruffini to review updates in lung cancer, mesothelioma, and thymic cancer.

      Source: www.ilcn.org
      Categories: Hem/Onc News and Journals, Latest Headlines
      Tweet Tweets with this article
      • Profile photo of 	IASLC
        IASLC

        Preview upcoming revisions to the TNM staging classification criteria during a special plenary session on Monday at #WCLC23. Read more in #ILCN: https://t.co/rJ1iD8KaLh #LCSM

    Load More
    ASCO 2025

    Advertisement

    Advertisement

    MashupMD
    © 2025 - Mashup Media LLC
    • Terms of Use
    • Privacy Policy
    • Cookie Settings